Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model

Sonoko Chujo, Fumiaki Shirasaki, Shigeru Kawara, Yutaka Inagaki, Takuro Kinbara, Makoto Inaoki, Masaharu Takigawa, Kazuhiko Takehara

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Skin fibrotic disorders such as systemic sclerosis (SSc) are characterized by an excessive production of extracellular matrix (ECM) and understood to develop under the influence of certain growth factors. Connective tissue growth factor (CTGF) is a cysteine-rich mitogenic peptide that is implicated in various fibrotic disorders and induced in fibroblasts after activation with transforming growth factor-β (TGF-β). To better understand the mechanisms of persistent fibrosis seen in SSc, we previously established an animal model of skin fibrosis induced by exogenous application of growth factors. In this model, TGF-β transiently induced subcutaneous fibrosis and serial injections of CTGF after TGF-β caused persistent fibrosis. To further define the mechanisms of skin fibrosis induced by TGF-β and CTGF in vivo, we investigated in this study, the effects of growth factors on the promoter activity of the proα2 (I) collagen (COL1A2) gene in skin fibrosis. For this purpose, we utilized transgenic reporter mice harboring the - 17 kb promoter sequence of the mouse COL1A2 linked to either a firefly luciferase gene or a bacterial β-galactosidase gene. Serial injections of CTGF after TGF-β resulted in a sustained elevation of COL1A2 mRNA expression and promoter activity compared with consecutive injection of TGF-β alone on day 8. We also demonstrated that the number of fibroblasts with activated COL1A2 transcription was increased by serial injections of CTGF after TGF-β in comparison with the injection of TGF-β alone. Furthermore, the serial injections recruited mast cells and macrophages. The number of mast cells Is reached a maximum on day 4 and remained relatively high up to day 8. In contrast to the kinetics of mast cells, the number of macrophages was increased on day 4 and continued to rise during the subsequent consecutive CTGF injections until day 8. These results suggested that CTGF maintains TGF-β-induced skin fibrosis by sustaining COL1A2 promoter activation and increasing the number of activated fibroblasts. The infiltrated mast cells and macrophages may also contribute to the maintenance of fibrosis.

Original languageEnglish
Pages (from-to)447-456
Number of pages10
JournalJournal of Cellular Physiology
Volume203
Issue number2
DOIs
Publication statusPublished - May 2005

Fingerprint

Connective Tissue Growth Factor
Transforming Growth Factors
Gene expression
Fibrosis
Collagen
Gene Expression
Injections
Skin
Mast Cells
Macrophages
Fibroblasts
Intercellular Signaling Peptides and Proteins
Genes
Systemic Scleroderma
Chemical activation
Galactosidases
Firefly Luciferases
Bacterial Genes
Transcription
Transgenic Mice

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model. / Chujo, Sonoko; Shirasaki, Fumiaki; Kawara, Shigeru; Inagaki, Yutaka; Kinbara, Takuro; Inaoki, Makoto; Takigawa, Masaharu; Takehara, Kazuhiko.

In: Journal of Cellular Physiology, Vol. 203, No. 2, 05.2005, p. 447-456.

Research output: Contribution to journalArticle

Chujo, Sonoko ; Shirasaki, Fumiaki ; Kawara, Shigeru ; Inagaki, Yutaka ; Kinbara, Takuro ; Inaoki, Makoto ; Takigawa, Masaharu ; Takehara, Kazuhiko. / Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model. In: Journal of Cellular Physiology. 2005 ; Vol. 203, No. 2. pp. 447-456.
@article{a01d5950dfef47799e080fd4d773f987,
title = "Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model",
abstract = "Skin fibrotic disorders such as systemic sclerosis (SSc) are characterized by an excessive production of extracellular matrix (ECM) and understood to develop under the influence of certain growth factors. Connective tissue growth factor (CTGF) is a cysteine-rich mitogenic peptide that is implicated in various fibrotic disorders and induced in fibroblasts after activation with transforming growth factor-β (TGF-β). To better understand the mechanisms of persistent fibrosis seen in SSc, we previously established an animal model of skin fibrosis induced by exogenous application of growth factors. In this model, TGF-β transiently induced subcutaneous fibrosis and serial injections of CTGF after TGF-β caused persistent fibrosis. To further define the mechanisms of skin fibrosis induced by TGF-β and CTGF in vivo, we investigated in this study, the effects of growth factors on the promoter activity of the proα2 (I) collagen (COL1A2) gene in skin fibrosis. For this purpose, we utilized transgenic reporter mice harboring the - 17 kb promoter sequence of the mouse COL1A2 linked to either a firefly luciferase gene or a bacterial β-galactosidase gene. Serial injections of CTGF after TGF-β resulted in a sustained elevation of COL1A2 mRNA expression and promoter activity compared with consecutive injection of TGF-β alone on day 8. We also demonstrated that the number of fibroblasts with activated COL1A2 transcription was increased by serial injections of CTGF after TGF-β in comparison with the injection of TGF-β alone. Furthermore, the serial injections recruited mast cells and macrophages. The number of mast cells Is reached a maximum on day 4 and remained relatively high up to day 8. In contrast to the kinetics of mast cells, the number of macrophages was increased on day 4 and continued to rise during the subsequent consecutive CTGF injections until day 8. These results suggested that CTGF maintains TGF-β-induced skin fibrosis by sustaining COL1A2 promoter activation and increasing the number of activated fibroblasts. The infiltrated mast cells and macrophages may also contribute to the maintenance of fibrosis.",
author = "Sonoko Chujo and Fumiaki Shirasaki and Shigeru Kawara and Yutaka Inagaki and Takuro Kinbara and Makoto Inaoki and Masaharu Takigawa and Kazuhiko Takehara",
year = "2005",
month = "5",
doi = "10.1002/jcp.20251",
language = "English",
volume = "203",
pages = "447--456",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model

AU - Chujo, Sonoko

AU - Shirasaki, Fumiaki

AU - Kawara, Shigeru

AU - Inagaki, Yutaka

AU - Kinbara, Takuro

AU - Inaoki, Makoto

AU - Takigawa, Masaharu

AU - Takehara, Kazuhiko

PY - 2005/5

Y1 - 2005/5

N2 - Skin fibrotic disorders such as systemic sclerosis (SSc) are characterized by an excessive production of extracellular matrix (ECM) and understood to develop under the influence of certain growth factors. Connective tissue growth factor (CTGF) is a cysteine-rich mitogenic peptide that is implicated in various fibrotic disorders and induced in fibroblasts after activation with transforming growth factor-β (TGF-β). To better understand the mechanisms of persistent fibrosis seen in SSc, we previously established an animal model of skin fibrosis induced by exogenous application of growth factors. In this model, TGF-β transiently induced subcutaneous fibrosis and serial injections of CTGF after TGF-β caused persistent fibrosis. To further define the mechanisms of skin fibrosis induced by TGF-β and CTGF in vivo, we investigated in this study, the effects of growth factors on the promoter activity of the proα2 (I) collagen (COL1A2) gene in skin fibrosis. For this purpose, we utilized transgenic reporter mice harboring the - 17 kb promoter sequence of the mouse COL1A2 linked to either a firefly luciferase gene or a bacterial β-galactosidase gene. Serial injections of CTGF after TGF-β resulted in a sustained elevation of COL1A2 mRNA expression and promoter activity compared with consecutive injection of TGF-β alone on day 8. We also demonstrated that the number of fibroblasts with activated COL1A2 transcription was increased by serial injections of CTGF after TGF-β in comparison with the injection of TGF-β alone. Furthermore, the serial injections recruited mast cells and macrophages. The number of mast cells Is reached a maximum on day 4 and remained relatively high up to day 8. In contrast to the kinetics of mast cells, the number of macrophages was increased on day 4 and continued to rise during the subsequent consecutive CTGF injections until day 8. These results suggested that CTGF maintains TGF-β-induced skin fibrosis by sustaining COL1A2 promoter activation and increasing the number of activated fibroblasts. The infiltrated mast cells and macrophages may also contribute to the maintenance of fibrosis.

AB - Skin fibrotic disorders such as systemic sclerosis (SSc) are characterized by an excessive production of extracellular matrix (ECM) and understood to develop under the influence of certain growth factors. Connective tissue growth factor (CTGF) is a cysteine-rich mitogenic peptide that is implicated in various fibrotic disorders and induced in fibroblasts after activation with transforming growth factor-β (TGF-β). To better understand the mechanisms of persistent fibrosis seen in SSc, we previously established an animal model of skin fibrosis induced by exogenous application of growth factors. In this model, TGF-β transiently induced subcutaneous fibrosis and serial injections of CTGF after TGF-β caused persistent fibrosis. To further define the mechanisms of skin fibrosis induced by TGF-β and CTGF in vivo, we investigated in this study, the effects of growth factors on the promoter activity of the proα2 (I) collagen (COL1A2) gene in skin fibrosis. For this purpose, we utilized transgenic reporter mice harboring the - 17 kb promoter sequence of the mouse COL1A2 linked to either a firefly luciferase gene or a bacterial β-galactosidase gene. Serial injections of CTGF after TGF-β resulted in a sustained elevation of COL1A2 mRNA expression and promoter activity compared with consecutive injection of TGF-β alone on day 8. We also demonstrated that the number of fibroblasts with activated COL1A2 transcription was increased by serial injections of CTGF after TGF-β in comparison with the injection of TGF-β alone. Furthermore, the serial injections recruited mast cells and macrophages. The number of mast cells Is reached a maximum on day 4 and remained relatively high up to day 8. In contrast to the kinetics of mast cells, the number of macrophages was increased on day 4 and continued to rise during the subsequent consecutive CTGF injections until day 8. These results suggested that CTGF maintains TGF-β-induced skin fibrosis by sustaining COL1A2 promoter activation and increasing the number of activated fibroblasts. The infiltrated mast cells and macrophages may also contribute to the maintenance of fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=16344369209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16344369209&partnerID=8YFLogxK

U2 - 10.1002/jcp.20251

DO - 10.1002/jcp.20251

M3 - Article

C2 - 15605379

AN - SCOPUS:16344369209

VL - 203

SP - 447

EP - 456

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 2

ER -